Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase

Jacobs, 1991, The cost of hospitalization for the late complications of diabetes in the United States, Diabet. Med., 8, S23, 10.1111/j.1464-5491.1991.tb02151.x Ray, 1996, Hospitalization and expenditures for the treatment of general medical conditions among the U.S. diabetic population in 1991, J. Clin. Endocrinol. Metab., 81, 3671, 10.1210/jc.81.10.3671 Abbud, 1995, Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: a statewide study: Myocardial Infarction Data Acquisition System Study Group, Am. Heart J., 130, 51, 10.1016/0002-8703(95)90235-X Abbott, 1988, The impact of diabetes on survival following myocardial infarction in men vs women: the Framingham Study, JAMA, 260, 3456, 10.1001/jama.260.23.3456 Thompson, 1994, Quantitative analysis of myocardial structure in insulin-dependent diabetes mellitus: effects of immediate and delayed insulin replacement, Proc. Soc. Exp. Biol. Med., 205, 294, 10.3181/00379727-205-43710 Kondo, 2004, Altered insulin signaling in retinal tissue in diabetic states, J. Biol. Chem., 279, 37997, 10.1074/jbc.M401339200 El-Remessy, 2005, Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI-3-kinase tyrosine nitration, J. Cell. Sci., 118, 243, 10.1242/jcs.01612 Kopp, 1998, Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the ‘French paradox’?, Eur. J. Endocrinol., 138, 619, 10.1530/eje.0.1380619 Fukuda, 2006, Beneficial effect of pharmacological intervention by resveratrol induces myocardial angiogenesis by upregulating VEGF and tyrosine kinase receptor, Flk-1/KDR, Cell. Biochem. Biophys., 44, 43, 10.1385/CBB:44:1:043 Jager, 1999, Relaxant effect of trans-resveratrol on isolated porcine coronary arteries, Arzneimittelforschung, 49, 207 Giovannini, 2001, Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys, J. Cardiovasc. Pharmacol., 37, 262, 10.1097/00005344-200103000-00004 Hattori, 2002, Pharmacological preconditioning with resveratrol: role of nitric oxide, Am. J. Physiol. Heart Circ. Physiol., 282, H1988, 10.1152/ajpheart.01012.2001 Naderali, 2002, Resveratrol induces vasorelaxation of mesenteric and uterine arteries from female guinea-pigs, Clin. Sci. (Lond.), 98, 537, 10.1042/CS19990303 Kaga, 2005, Resveratrol enhances neovascularization in the infracted rat myocardium through the induction of thioredoxin-1, hemeoxygenase-1 and vascular endothelial growth factor, J. Mol. Cell. Cardiol., 39, 813, 10.1016/j.yjmcc.2005.08.003 D'Amico, 2001, High glucose induces ventricular instability and increases vasomotor tone in rats, Diabetologia, 44, 464, 10.1007/s001250051644 Arner, 2000, Physiological functions of thioredoxin and thioredoxin reductase, Eur. J. Biochem., 267, 6102, 10.1046/j.1432-1327.2000.01701.x Kietzmann, 2003, Transcriptional regulation of heme oxygenase-1 gene expression by MAP kinases of the JNK and p38 pathways in primary cultures of rat hepatocytes, J. Biol. Chem., 278, 17927, 10.1074/jbc.M203929200 Terry, 1998, Effect of tumor necrosis factor-α and interleukin-1α on heme oxygenase-1 expression in human endothelial cells, Am. J. Physiol., 274, H883 Andre, 2003, Heme oxygenase-1 induction by endogenous nitric oxide: influence of intracellular glutathione, FEBS Lett., 546, 223, 10.1016/S0014-5793(03)00576-3 Maines, 1988, Heme oxygenase: Function, multiplicity, regulatory mechanisms, and clinical applications, FASEB J., 2, 2557, 10.1096/fasebj.2.10.3290025 Otterbein, 2000, Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway, Nat. Med., 6, 422, 10.1038/74680 Siow, 1999, Heme oxygenase-carbon monoxide signaling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide?, Cardiovasc. Res., 41, 385, 10.1016/S0008-6363(98)00278-8 Melo, 2002, Gene therapy strategy for long term myocardial protection using adeno-associated virus-mediated delivery of heme-oxygenase gene, Circulation, 105, 602, 10.1161/hc0502.103363 Maulik, 2000, Regulation of cardiomyocyte apoptosis by redox-sensitive transcription factors, FEBS Lett., 485, 7, 10.1016/S0014-5793(00)02174-8 Engelman, 1995, Hypoxic preconditioning preserves antioxidant reserve in the working rat heart, Cardiovasc. Res., 29, 133 Sasaki, 1999, Redox regulation of NFkB and AP-1 in ischemic reperfused heart, Antioxid. Redox Signal., 1, 317, 10.1089/ars.1999.1.3-317 Thirunavukkarasu, 2006, Niacin bound chromium enhances myocardial protection from ischemia reperfusion injury, Am. J. Physiol. Heart. Circ. Physiol., 291, H820, 10.1152/ajpheart.00134.2006 Kajstura, 1996, Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats, Lab. Invest., 74, 86 Maulik, 1998, Ischemic preconditioning triggers tyrosine kinase signaling: a potential role for MAPKAP kinase 2, Am. J. Physiol., 275, H1857 Baron, 1997, Role of blood flow in the regulation of muscle glucose uptake, Annu. Rev. Nutr., 17, 487, 10.1146/annurev.nutr.17.1.487 Evans, 2005, The molecular basis for oxidative stress-induced insulin resistance, Antioxid. Redox Signal., 7, 1040, 10.1089/ars.2005.7.1040 Kim, 2006, Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms, Circulation, 113, 1888, 10.1161/CIRCULATIONAHA.105.563213 Abraham, 2004, Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes, Am. J. Physiol. Heart. Circ. Physiol., 287, H2468, 10.1152/ajpheart.01187.2003 Penumathsa, 2007, Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat, J. Mol. Cell. Cardiol., 42, 508, 10.1016/j.yjmcc.2006.10.018 Holmgren, 1985, Thioredoxin, Annu. Rev. Biochem., 54, 237, 10.1146/annurev.bi.54.070185.001321 Luthman, 1982, Rat liver thioredoxin and thioredoxin reductase: purification and characterization, Biochemistry, 21, 6628, 10.1021/bi00269a003 Nakamura, 1997, Redox regulation of cellular activation, Annu. Rev. Immunol., 15, 351, 10.1146/annurev.immunol.15.1.351 Bertini, 1999, Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells, J. Exp. Med., 189, 1783, 10.1084/jem.189.11.1783 Hotta, 1998, Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes, J. Exp. Med., 188, 1445, 10.1084/jem.188.8.1445 Quan, 2004, Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats, Biochem. Biophys. Res. Commun., 315, 509, 10.1016/j.bbrc.2004.01.086 Liu, 2005, Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice, Diabetes, 54, 778, 10.2337/diabetes.54.3.778 Stocker, 1987, Bilirubin is an antioxidant of possible physiological importance, Science, 235, 1043, 10.1126/science.3029864 Akamatsu, 2004, Heme oxygenase-1 derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury, FASEB J., 18, 771, 10.1096/fj.03-0921fje Won, 2006, A protective role for Heme oxygenase -1 in INS-1 cells and rat islets that are exposed to high glucose conditions, J. Korean Med. Sci., 21, 418, 10.3346/jkms.2006.21.3.418 Chen, 2007, Influence of heme oxygenase-1 gene transfer on the viability and function of rat islets in in vitro culture, World J. Gastroenterol., 21, 1053, 10.3748/wjg.v13.i7.1053 Shen, 2006, Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy, Diabetes, 55, 798, 10.2337/diabetes.55.03.06.db05-1039 Ziche, 1994, Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P, J. Clin. Invest., 94, 2036, 10.1172/JCI117557 Jozkowicz, 2001, Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF, Cardiovasc. Res., 51, 773, 10.1016/S0008-6363(01)00344-3 Nor, 1999, Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression, Am. J. Pathol., 154, 375, 10.1016/S0002-9440(10)65284-4 Gerber, 1998, Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation, J. Biol. Chem., 273, 30336, 10.1074/jbc.273.46.30336